FusionPharm Completes $1million Funding
25 Fevereiro 2014 - 11:00AM
FusionPharm, Inc. (OTC: FSPM), manufacturer of the PharmPod™
(www.pharmpods.com) professional cultivation system, is pleased to
announce that it has completed a $1million round of equity
funding. Management intends to use the funds to complete
outfitting of its recently expanded manufacturing facilities,
provide for construction of new sales centers in key markets and to
provide operations funding for acquisition of key personnel.
About FusionPharm Inc.
(FSPM)
FusionPharm, Inc. (FSPM)
(www.fusionpharminc.com) was organized to capitalize on
opportunities present in the rapidly growing vertical farming and
cannabis industries. FusionPharm's primary focus is the development
and deployment of the patent pending PharmPods™ advanced hydroponic
commercial cultivation systems. PharmPods are constructed from
standard ISO steel shipping containers that are repurposed for use
in indoor controlled environment agriculture. Modular, stackable,
cost competitive and financeable, PharmPods have become the
industry leader for professional, commercial scale indoor plant
cultivation
Cautionary Language Concerning
Forward-Looking Statements
This release contains "forward-looking statements" that include
information relating to future events and future financial and
operating performance. The words "may," "would," "will,"
"expect," "estimate," "can," "believe," "potential" and similar
expressions and variations thereof are intended to identify
forward-looking statements. Forward-looking statements should not
be read as a guarantee of future performance or results.
Forward-looking statements are based on information
available at the time they are made and/or management's good faith
belief as of that time with respect to future events, and are
subject to risks and uncertainties that could cause actual
performance or results to differ materially from those expressed in
or suggested by the forward-looking statements. No information in
this press release should be construed as an indication of the
Company's future financial performance, revenues or stock
price. The Company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
info@fusionpharminc.com
www.fusionpharminc.com
www.pharmpods.com
CONTACT:
FusionPharm, Inc.
(720) 458-0686
info@fusionpharminc.com
Fusion Pharm (CE) (USOTC:FSPM)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Fusion Pharm (CE) (USOTC:FSPM)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
Notícias em tempo-real sobre Fusion Pharm Inc (CE) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de